Imène Hamaidi

Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells

Imène Hamaidi, Lin Zhang, Nayoung Kim et al. · Cell Metabolism · 2020 · 153 citations · Full text

Tumor-reactive T Cells, Cancer Immunosurveillance, Cell Signaling +12

Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial

Sungjune Kim, Evan Wuthrick, Dukagjin Blakaj et al. · The Lancet · 2022 · 126 citations · Full text

Open Label, Radiation Therapy, Medicine +6

An <scp>FGFR</scp> 3/ <scp>MYC</scp> positive feedback loop provides new opportunities for targeted therapies in bladder cancers

Mélanie Mahé, Florent Dufour, Hélène Neyret‐Kahn et al. · EMBO Molecular Medicine · 2018 · 87 citations · Full text

Epigenetic state determines the in vivo efficacy of STING agonist therapy

Rana Falahat, Anders Berglund, Patricio Perez-Villarroel et al. · Nature Communications · 2023 · 73 citations · Full text

Methylation of immune synapse genes modulates tumor immunogenicity

Anders Berglund, Matthew N. Mills, Ryan M. Putney et al. · Journal of Clinical Investigation · 2019 · 53 citations · Full text

T-regulatory Cell, Immunology, Immunotherapy +16